Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

Abstract Background This trial aimed to evaluate the anti-obesity effects and safety of Neoagaro-oligosaccharides (NAOs) in humans in a 16 week, randomized, double-blind, placebo-controlled clinical trial. Methods One hundred overweight or obese subjects with a body mass index of 23 to 34.9 kg/m2 an...

Full description

Bibliographic Details
Main Authors: Hyang-Im Baek, Ki-Chan Ha, Yu Kyung Park, Je Hyeon Lee, Eun Joo Kim, Hye-Jeong Ko, Jong Cheon Joo
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Neoagaro-oligosaccharides
Overweight
Obesity
Visceral fat
Body weight
Clinical trial
Online Access:https://doi.org/10.1186/s12906-023-04206-2

Internet

https://doi.org/10.1186/s12906-023-04206-2

Similar Items